1-3 of 3
Mikio Ueda, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Minimal Residual Disease Assessment Using Euroflow-NGF in Patients with Multiple Myeloma Treated with a Combination of Carfilzomib, Lenalidomide, and Dexamethasone (KRD)

Takeshi Yoroidaka, MD, Hiroyuki Takamatsu, MD PhD, Takeshi Yamashita, MD, Ryoichi Murata, MD, Kyoko Yoshihara, MD PhD, Satoshi Yoshihara, MD PhD, Mikio Ueda, MD PhD, Shinji Nakao, MD PhD, Kosei Matsue, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3130.
https://doi.org/10.1182/blood-2019-126552
Published: 2019
Journal Articles

Comparison of Minimal Residual Disease Detection between the Manual and Automated Gating Strategies of Euroflow Next-Generation Flow in Patients with Multiple Myeloma

Hiroyuki Takamatsu, MD PhD, Takeshi Yoroidaka, MD, Takeshi Yamashita, MD, Ryoichi Murata, MD, Mikio Ueda, MD PhD, Shinji Nakao, MD PhD, Kosei Matsue, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3083.
https://doi.org/10.1182/blood-2019-122398
Published: 2019
Journal Articles

Unique Pharmacokinetic Self-Potentiation of Idarubicin through Induction of Carbonyl Reducing Enzymes in Contrast to Other Anthracyclines, Pharmacologic and Clinical Study

Shinji Kishi, MD, PhD, Taro Yamashita, MD, PhD, Toshihiro Fukushima, MD, PhD, Yoshimasa Urasaki, MD, PhD, Tamami Seo, MD, PhD, Toru Nakamura, MD, PhD, Toshihiro Haba, MD, PhD, Ken-ichi Kamiya, MD, PhD, Jun Murakami, MD, PhD, Mikio Ueda, MD, PhD, Shinji Nakao, MD, PhD, Takanori Ueda, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4025.
https://doi.org/10.1182/blood.V112.11.4025.4025
Published: 2008